Candel Therapeutics Inc. (NASDAQ: CADL)
$7.18
+0.5550 ( +8.38% ) 474.7K
Candel Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing viral immunotherapies to help patients fight cancer. The company has established two clinical-stage viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.
Market Data
Open
$7.18
Previous close
$6.62
Volume
474.7K
Market cap
$210.67M
Day range
$6.47 - $7.30
52 week range
$0.66 - $14.30
SEC Fillings
| Form Type | Description | Pages | Date |
|---|---|---|---|
| 10-k/a | Quarterly Reports | 17 | Apr 25, 2024 |
| 8-k | 8K-related | 13 | Apr 25, 2024 |
| 8-k | 8K-related | 13 | Apr 11, 2024 |
| 8-k | 8K-related | 13 | Apr 09, 2024 |
| 8-k | 8K-related | 13 | Apr 04, 2024 |
| 10-k | Annual reports | 90 | Mar 28, 2024 |
| 8-k | 8K-related | 15 | Mar 28, 2024 |
| 8-k | 8K-related | 14 | Mar 06, 2024 |
| 8-k | 8K-related | 14 | Feb 13, 2024 |
| 3 | Insider transactions | 2 | Jan 19, 2024 |